Bone Marrow Derived Adult Liver Stem Cell Recruitment After Major Liver Resections: Correlation With Liver Regeneration and Hepatic Function
NCT00605800 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2009-03-19
Summary
The results of this study may or may not establish useful baseline data, which will help us understand how bone marrow derived adult liver stem cells behave in normal healthy adults/volunteers (the control group), and in patients undergoing liver surgery. The bone marrow is located within your bones and is the organ which is responsible to produce blood cells and stem cells. Bone marrow derived adult liver stem cells are normal cells in your bone marrow. These liver stem cells have the capacity to regenerate or in other words to rebuild the liver after liver surgery, a process called liver regeneration. These cells are very important for the liver to regrow its tissue after liver surgery. These cells are thought to be activated in times of need by the liver.
Situations like liver surgery are one of these occasions when the liver will need the "extra help" from these stem cells.
The results of this study will establish the baseline data necessary for the understanding of how to harness the ability of these stem cells in times of liver surgery. Improvements in the ability of the liver to regrow after surgery is thought to decrease complications related to liver surgery. Harnessing this unique ability of stem cells may be utilized in the future to enhance the regrowing process of liver tissue after liver surgery, called liver regeneration.
Conditions
Interventions
- OTHER
-
blood drawn
Baseline levels of bone marrow derived liver stem cells from normal healthy volunteers, which will be drawn once Two 5ml blue tubes).
- OTHER
-
blood drawn
At the time of preoperative testing, patients will have two extra test tubes (5cc blue top) of blood drawn for determination of pre-operative base line levels of bone marrow derived liver stem cells in peripheral blood. Intraoperatively, blood will be drawn after liver resection (two tubes of 5cc blue top). Two extra tube of blood will be drawn at the same time of routine postoperative blood drawing to determine levels of bone marrow derived liver stem cells in peripheral blood on post-operative days #1, and #3.
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
Ronald DeMatteo, MD · Memorial Sloan Kettering Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-03-31
- Primary Completion
- 2009-03-31
- Completion
- 2009-03-31
More Related Trials
-
UARK 2006-28 Human Cord Blood Transplantation in Advanced Hematological Malignancies
NCT00578045 ·Status: WITHDRAWN ·Phase: PHASE1
-
Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant
NCT00725062 ·Status: TERMINATED ·Phase: PHASE1
-
Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors
NCT03233074 ·Status: TERMINATED
-
Comparison of Peripheral Blood Stem Cell Transplantation With Bone Marrow Transplantation for the Treatment of Serious Hematological Malignancies
NCT00275678 ·Status: COMPLETED ·Phase: PHASE3
-
Collection of Blood and Bone Marrow From Healthy Volunteers and Patients for Research Purposes
NCT00001627 ·Status: COMPLETED
-
The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells From Normal Volunteers and Volunteers With Lymphoid or Hematologic Malignancies
NCT00001432 ·Status: COMPLETED
-
Bone Marrow Cell Gene Transfer in Individuals With Fanconi Anemia
NCT00272857 ·Status: COMPLETED ·Phase: PHASE1
-
Allogenic Bone Marrow Stem Cell Transplantation in Liver Failure
NCT01221454 ·Status: UNKNOWN ·Phase: PHASE2
-
Mobilization and Handling of Stem Cells for Transplant From Healthy Volunteers With Sickle Cell Trait
NCT00005782 ·Status: COMPLETED ·Phase: PHASE3
-
Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation
NCT02598752 ·Status: COMPLETED
-
Musculoskeletal Outcomes After Bone Marrow Transplant
NCT00558948 ·Status: COMPLETED
-
Bone Marrow Grafting for Leukemia and Lymphoma
NCT00186147 ·Status: ENROLLING_BY_INVITATION
-
Evaluating the Safety and Effectiveness of Bone Marrow Transplants in Children With Sickle Cell Disease (BMT CTN 0601)
NCT00745420 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Quality of Life in Patients Undergoing More Intensive Versus Less Intensive Chemotherapy and Radiation Preceding a Bone Marrow Transplant
NCT00004994 ·Status: COMPLETED
-
Biospecimen Procurement for Immunological Landscape Studies Following Hematopoietic Cell Transplantation
NCT04428918 ·Status: WITHDRAWN
-
Evaluation, Treatment, and Training for Patients With Blood Disorders
NCT00001397 ·Status: COMPLETED
-
Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor Cells
NCT01624701 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Mobilization of Mesenchymal Stem Cells During Liver Transplantation
NCT02557724 ·Status: COMPLETED
-
Cell Cycle Regulatory Gene Study in Patients With Myeloproliferative Disorders
NCT02663648 ·Status: WITHDRAWN
-
Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma
NCT00900055 ·Status: COMPLETED
-
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
NCT01758042 ·Status: COMPLETED ·Phase: NA
-
Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201)
NCT00075816 ·Status: COMPLETED ·Phase: PHASE3
-
Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia
NCT00001623 ·Status: COMPLETED ·Phase: NA
-
New York Blood Center National Cord Blood Program
NCT00212407 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer
NCT00126477 ·Status: COMPLETED